[ad_1]
Kenbara: There is a bacteria in the world that has become the enemy of humans’ life, the name is Staphylococcus Arius. It is also called ‘Golden Staff’. It is not a minor bacterium. Due to this alone, about 1 million people die every year. When antibiotics also started to give up against this ‘superbug’, scientists had to think something different. And now, researchers from Melbourne have developed a technology that can become a decisive weapon against this deadly superbug.
Scientists of the Doherty Institute, Peter Doharti Institute for Infection and Immunity, have designed a technique: real -time genome sequentials. If you understand in easy language, this is a test that tracks the DNA live of bacteria, that too while living in the patient’s body.
How is it different in traditional methods?
This technique can not only improve treatment, but can also know how the infection is spreading in the body and when it was mutated. This test also gives constant information during the treatment of the patient, not after the treatment is over.
In this study published in a journal called Nature Communications, this technique was tested on patients associated with seven hospitals in Melbourne. Research found that in one-third of the patients who had Staphylococcus an infection, bacteria had mutated during treatment. Meaning, the medicine which was effective earlier, became ineffective after a few days.
What will happen in future?
Why is this discovery important?
In today’s time, the immunity of bacteria against medicines, ie medicines, has become a global crisis. Who has already warned that if the situation does not improve, then by 2050, superbugs can kill 1 crore people every year. Therefore, this new technology is not just a medical innovation, but a global health brakethrough. With this, not only the patients will get the right treatment on time, but the spread of bacteria in hospitals will also be stopped.
[ad_2]
